The global hemophilia treatment market is on a strong growth trajectory, with projections indicating a rise from USD 12.1 billion in 2024 to a remarkable USD 18.7 billion by 2034. This growth, driven ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

The shift towards cashless transactions has driven a surge in demand for eWallet apps that offer seamless, secure, and instant payments. Whether for peer-to-peer transfers, in-store payments, or ...

Analysts believe this move will streamline Bloomin’ Brands, Inc.’s (NASDAQ:BLMN) business and boost operational efficiency by allowing it to concentrate on its domestic market.

The business, which has offices in New York and Bengaluru, provides a complete AI-driven CLM solution that automates ... freeing them up to concentrate on higher-value work rather than administrative ...

An infusion is similar to an intravenous (IV) injection and delivers medication directly into the bloodstream. Some people may receive medication infusions regularly, while others may need them ...

The Bluntness Editorial Staff is dedicated to bring you the many stories of cannabis culture - stories that speak to the enthusiast and expert in an unfiltered but factual manner. Everyday, our ...

New Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct the Phase I clinical trial ...